AMGN Stock Analysis: Buy, Sell, or Hold?
AMGN - Amgen Inc
$439.33
5.60 (1.29%)
▲
5d:
+5.81%
30d:
+18.26%
90d:
+30.2%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 21, 2026 at $438.53 · last confirmed Aug 21, 2026
Strength: 7.6/10
Get Alerted When AMGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AMGN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AMGN shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$478.34
Based on 5.0% avg growth
INTRINSIC VALUE TODAY
$297.01
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AMGN is currently trading at $439.33, which is considered extended relative to its 30-day fair value range of $368.27 to $419.67. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.0) compared to its historical average (15.4). At these levels, the market is pricing in 5.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AMGN is in a strong uptrend. The price is approaching resistance at $443.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AMGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $388.48. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AMGN is in a strong uptrend. The price is approaching resistance at $443.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AMGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $388.48. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$368.27 -
$419.67
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
18.1%
Protect Your Profits
AMGN is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 11.6% above Wall St target ($388.48)
- NEUTRAL: Trading at premium valuation - market expects 5.4% growth which is achievable
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$368.27 -
$419.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$406.42
Resistance Level
$443.20
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.01
Wall Street Target
$388.48
(-11.6%)
Revenue Growth (YoY)
9.5%
Earnings Growth (YoY)
64.9%
Profit Margin
22.9%
Valuation Premium vs History
+5.4% premium
PE vs Historical
18.0 vs 15.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.4%
(market-implied from PE analysis)
1-Year Target
$463.05
(+5%)
2-Year Target
$488.06
(+11%)
3-Year Target
$514.41
(+17%)
3-Yr Target (if PE normalizes)
(PE: 18→15)
PE COMPRESSION
$439.94
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 5.9%)
$581.30
(+32%)
Base:
(SPY PE: 18.0, Growth: 5.9%)
$521.55
(+19%)
Bear:
(PE: 15.3, Growth: 5.9%)
$443.32
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 27.47 | Current EPS (TTM): $15.79
Bull Case
$737.19
(+68%)
Analyst growth 54.5%, PE expands to 30.2
Base Case
$670.17
(+53%)
Market implied 54.5%, PE stable at 27.5
Bear Case
$294.94
(-33%)
Severe decline -20.0%, PE contracts to 23.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 2:10 AM ET
Data refreshes hourly during market hours. Next update: 3:10 AM
Data refreshes hourly during market hours. Next update: 3:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMGN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Maria Elvira Salazar
BUY
2026-03-24
David Taylor
SELL
2026-02-26
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1311 | 37 SELL |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 34 SELL |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$276 | 41 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$238 | 42 HOLD |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$138 | 45 HOLD |
Advanced AMGN Option Strategies
Professional options setups generated by AI based on today's AMGN price and gamma walls.
